SEC v. Robert Lozuk; and Individual A, No. LR-24222, Southern District of California (Aug. 1, 2018) — Press Release
raw: Lozuk
Lozuk, No. 3:18-cv-01765-LAB (Aug. 1, 2018)
Robert Lozuk, former Senior Vice President at Sequenom, Inc., settled insider trading charges for tipping his friend about LabCorp's $400 million acquisition bid, resulting in a $26,643 profit and a $26,643 penalty.
Robert Lozuk, former Senior Vice President at Sequenom, Inc., was charged with insider trading for tipping his friend about LabCorp's $400 million acquisition bid in July 2016. The tip led to his friend purchasing 18,000 Sequenom shares, resulting in a profit of $26,643 after the public announcement. Lozuk agreed to settle charges, including a penalty of $26,643, a permanent injunction, and a five-year bar from acting as an officer or director of a public company.
Robert Lozuk, former Senior Vice President at Sequenom, Inc., was charged with insider trading for tipping his friend, Individual A, about LabCorp's pending $400 million acquisition of Sequenom in July 2016. The tip was made in violation of Lozuk's confidentiality obligations as a Senior Vice President of Sequenom. Individual A used the nonpublic information to purchase 18,000 Sequenom shares, resulting in a profit of $26,643 after the public announcement, which caused Sequenom's stock price to surge 176%. Lozuk settled the charges without admitting or denying guilt, agreeing to a permanent injunction, a five-year bar from acting as an officer or director of a public company, and a $26,643 penalty. Individual A, who cooperated with the SEC, entered a deferred prosecution agreement to disgorge the same $26,643 in profits and avoid prosecution for two years if he complies with securities laws. The SEC's investigation was led by Adrienne Gurley and received assistance from the Financial Industry Regulatory Authority.
Exhibits & Attached Documents (2)
Extracted insights
- $27K $26,643 $10K–$100K
- $26K $26,000 $10K–$100K
- person Individual a
- scheme_term insider trading
- scheme_term lozuk for insider trading
- person robert lozuk
- SEC charges Lozuk for insider trading
- Lozuk agreed to settle charges
- Lozuk tipped Individual A
- Lozuk engaged in insider trading
- Lozuk tipped friend
- Robert Lozuk tipped his friend about Laboratory Corporation of America Holding's bid to acquire Sequenom in a July 2016 tender offer
- SEC charged Robert Lozuk for insider trading
- Robert Lozuk agreed to settle charges that he engaged in insider trading
- Robert Lozuk tipped his friend about Laboratory Corporation of America Holding's bid to acquire Sequenom
- SEC alleges that Robert Lozuk engaged in insider trading
- Robert Lozuk was formerly Sequenom's Senior Vice President of Commercial Operations
- Laboratory Corporation of America Holding bid to acquire Sequenom in a July 2016 tender offer
- SEC charges Robert Lozuk for insider trading
- Robert Lozuk engaged in insider trading after tipping his friend
- Robert Lozuk settled charges insider trading
- Robert Lozuk tipped Individual A
- Sequenom acquired by LabCorp
- SEC alleges insider trading by Robert Lozuk
- SEC filed complaint against Robert Lozuk
- LabCorp made bid to acquire Sequenom
- Robert Lozuk was Senior Vice President Sequenom
SEC Charges Former Corporate Officer for Insider Trading Litigation Release No. 24222 / August 1, 2018 Securities and Exchange Commission v. Lozuk, No. 3:18-cv-01765-LAB-BGS (S.D. Cal., filed July 31, 2018) A former Senior Vice President at Sequenom, Inc. ("Sequenom") has agreed to settle charges that he engaged in insider trading after tipping his friend about Laboratory Corporation of America Holding's ("LabCorp") bid to acquire Sequenom in a July 2016 tender offer. The SEC's complaint alleges that Robert Lozuk, who was formerly Sequenom's Senior Vice President of Commercial Operations, tipped his friend ("Individual A") about the pending acquisition during a social event they both attended a week before the public announcement. According to the complaint, Lozuk was not only subject to Sequenom's written policy and to certain obligations as an officer of the company, but he had also signed a confidentiality letter acknowledging his obligation not to disclose to anyone the company's plans. Nevertheless, Lozuk tipped Individual A, and over the next two trading days Individual A purchased a total of 18,000 Sequenom shares. On the date of the public announcement, Sequenom's stock price increased 176%, allowing Individual A to sell his shares that same day for a profit of over $26,000. Without admitting or denying the allegations, Lozuk agreed to the entry of a final judgment permanently enjoining him from future violations of Sections 10(b) and 14(e) of the Securities Exchange Act of 1934 and Rules 10b-5 and 14e-3 thereunder, and to a five-year bar prohibiting him from acting as an officer or director of a public company. Lozuk will pay a penalty of $26,643. Individual A, who provided timely and valuable assistance to the SEC's investigation, entered into a deferred prosecution agreement wherein he agreed to disgorge his ill-gotten gains of $26,643, and among other things, agreed not to violate the federal securities laws for the deferred period of two years. The SEC's investigation was conducted by Adrienne Gurley and supervised by Marc Blau. The SEC appreciates the assistance of the Financial Industry Regulatory Authority. SEC Complaint Deferred Prosecution AgreementSEC Charges Former Corporate Officer for Insider Trading Litigation Release No. 24222 / August 1, 2018 Securities and Exchange Commission v. Lozuk, No. 3:18-cv-01765-LAB-BGS (S.D. Cal., filed July 31, 2018) A former Senior Vice President at Sequenom, Inc. ("Sequenom") has agreed to settle charges that he engaged in insider trading after tipping his friend about Laboratory Corporation of America Holding's ("LabCorp") bid to acquire Sequenom in a July 2016 tender offer. The SEC's complaint alleges that Robert Lozuk, who was formerly Sequenom's Senior Vice President of Commercial Operations, tipped his friend ("Individual A") about the pending acquisition during a social event they both attended a week before the public announcement. According to the complaint, Lozuk was not only subject to Sequenom's written policy and to certain obligations as an officer of the company, but he had also signed a confidentiality letter acknowledging his obligation not to disclose to anyone the company's plans. Nevertheless, Lozuk tipped Individual A, and over the next two trading days Individual A purchased a total of 18,000 Sequenom shares. On the date of the public announcement, Sequenom's stock price increased 176%, allowing Individual A to sell his shares that same day for a profit of over $26,000. Without admitting or denying the allegations, Lozuk agreed to the entry of a final judgment permanently enjoining him from future violations of Sections 10(b) and 14(e) of the Securities Exchange Act of 1934 and Rules 10b-5 and 14e-3 thereunder, and to a five-year bar prohibiting him from acting as an officer or director of a public company. Lozuk will pay a penalty of $26,643. Individual A, who provided timely and valuable assistance to the SEC's investigation, entered into a deferred prosecution agreement wherein he agreed to disgorge his ill-gotten gains of $26,643, and among other things, agreed not to violate the federal securities laws for the deferred period of two years. The SEC's investigation was conducted by Adrienne Gurley and supervised by Marc Blau. The SEC appreciates the assistance of the Financial Industry Regulatory Authority. SEC Complaint Deferred Prosecution Agreement